Inactive Instrument
MELA Sciences Inc Stock Nasdaq
Stocks
US55277R3084
Advanced Medical Equipment & Technology
OTC Markets Traded| Market Cap | 29.44K 25.27K 23.72K 21.66K 40.88K 2.81M 41.08K 281K 109K 1.42M 111K 108K 4.69M | P/E 2024 |
-1.1x | P/E 2025 | -0.94x |
|---|---|---|---|---|---|
| Enterprise Value | 8.39M 7.2M 6.76M 6.17M 11.64M 800M 11.7M 79.94M 30.98M 403M 31.48M 30.8M 1.34B | EV / Sales 2024 |
0.64x | EV / Sales 2025 | 0.51x |
| Free-Float |
65.54% | Yield 2024 * |
-
| Yield 2025 | - |
Last Transcript: MELA Sciences Inc
| 1 day | -2.61% |
| Manager | Title | Age | Since |
|---|---|---|---|
Erica Jordan
CEO | Chief Executive Officer | - | 2026-07-11 |
Shmuel Gov
COO | Chief Operating Officer | - | 2023-11-13 |
John Gillings
AUD | Comptroller/Controller/Auditor | 51 | 2024-11-12 |
| Director | Title | Age | Since |
|---|---|---|---|
Uri Geiger
CHM | Chairman | 58 | 2023-07-02 |
| Director/Board Member | 87 | 2018-05-28 | |
Irit Yaniv
BRD | Director/Board Member | 61 | 2024-03-26 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -2.61% | +0.90% | - | - | 29.44K | ||
| +0.72% | +3.18% | +29.59% | +16.11% | 232B | ||
| -0.40% | +1.97% | +4.56% | -17.53% | 152B | ||
| -0.58% | -6.94% | -21.96% | +22.77% | 131B | ||
| -3.29% | -6.98% | -54.53% | -10.06% | 72.26B | ||
| -1.11% | -1.80% | -16.89% | -14.19% | 51.57B | ||
| +0.25% | -1.37% | +12.00% | +19.72% | 52.38B | ||
| -1.21% | -1.69% | +29.15% | +27.41% | 43.71B | ||
| -0.01% | -0.02% | +40.39% | +47.72% | 40.72B | ||
| +0.37% | +9.71% | +127.80% | +42.17% | 33.97B | ||
| Average | -0.69% | +3.90% | +16.68% | +14.90% | 90.01B | |
| Weighted average by Cap. | -0.27% | +3.71% | +9.58% | +10.15% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 33.56M 28.81M 27.04M 24.69M 46.6M 3.2B 46.83M 320M 124M 1.61B 126M 123M 5.35B | 30.7M 26.35M 24.73M 22.59M 42.62M 2.93B 42.83M 293M 113M 1.48B 115M 113M 4.89B |
| Net income | -10.09M -8.66M -8.13M -7.42M -14.01M -962M -14.07M -96.16M -37.26M -485M -37.87M -37.05M -1.61B | -6.26M -5.37M -5.04M -4.61M -8.69M -597M -8.74M -59.69M -23.13M -301M -23.51M -23M -998M |
| Net Debt | 9.18M 7.88M 7.39M 6.75M 12.74M 875M 12.81M 87.5M 33.91M 442M 34.46M 33.71M 1.46B | 8.36M 7.17M 6.73M 6.15M 11.6M 797M 11.66M 79.66M 30.87M 402M 31.37M 30.69M 1.33B |
Employees
-

















